LEE N. NEWCOMER, M.D. - Corporate Board Profile

MYRIAD GENETICS INC

Filing Date	Source Excerpt
2019-10-16	Lee N. Newcomer (2) 66 Director ... Member of the Compensation Committee ... The following table shows the total compensation paid or accrued during the fiscal year ended June 30, 2019 to each of our nonemployee directors ... Lee N. Newcomer, M.D. 0 Fees Earned or Paid in Cash, 0 Restricted Stock Unit Awards, 0 Total.
2020-10-15	Lee N. Newcomer, M.D., was appointed as a member of the Board of Directors in September 2019... The Nominating and Governance Committee currently has four members: Dr. Langer (chair), Dr. Henderson, Ms. Phanstiel, and Ms. Reitan... Our former Strategic Committee was renamed and refocused as the Research and Product Innovation Committee in 2020... This committee currently has five members: Dr. Newcomer (chair), Dr. Gilbert, Dr. Dreismann, Dr. Skovronsky, and Mr. Spiegelman... The following table shows the total compensation paid or accrued during the fiscal year ended June 30, 2020 to each of our nonemployee directors... Lee N. Newcomer, M.D. 70,250 300,005 370,255
2021-04-15	Lee Newcomer, M.D., was appointed as a member of the Board of Directors in September 2019... Age: 69... Committees: Compensation and Human Capital Committee (Chair)... Director Compensation Table: Lee N. Newcomer Fees Earned or Paid in Cash: 61,000, Stock Awards: 299,984, Total: 360,984.
2023-04-12	Lee Newcomer, M.D., was appointed as a member of the Board in September 2019. Dr. Newcomer currently manages his own consulting business, Lee N. Newcomer Consulting, LLC, and previously held senior executive roles at United Healthcare including Senior Vice President for Oncology and Genetics, Chief Medical Officer and Senior Vice President of Health Policy and Strategy for UnitedHealth Group. Dr. Newcomer also worked for Vivius, Inc., a consumer directed health plan, holding the position of Executive Vice President and Chief Medical Officer. Dr. Newcomer received a Master’s Degree in Healthcare Administration & Management from the University of Wisconsin, Madison, an M.D. from the University of Nebraska, Omaha, and a B.S. from Nebraska Wesleyan University. Dr. Newcomer currently serves on the board of Cellworks Group Inc., a private precision medicine company and Coherus BioSciences, Inc., a public biopharmaceutical company. He also served on the board of directors of Park Nicollet Health Systems, a hospital health care system with approximately 1,000 physicians and 400 beds, for ten years including two years as Chairman. The Board has determined that Dr. Newcomer should serve on the Board for the following reasons: His extensive reimbursement and managed care experience will aid the Company in its efforts to expand reimbursement for its new innovative precision medicine tests. He provides the Board with expertise on the medical insurance industry based on his extensive experience in several senior positions at UnitedHealth Group, Inc. and CIGNA Corporation. Additionally, Dr. Newcomer’s medical background provides the Board with expertise in developing predictive, personalized and prognostic testing products. Furthermore, Dr. Newcomer brings extensive business management experience from his 28 years of work in the managed care and pharmaceutical industries.
2024-04-17	Lee Newcomer, M.D., was appointed as a member of the Board in September 2019... The following table shows the total compensation paid or accrued during the year ended December 31, 2023 to each of our non-employee directors who served during fiscal year 2023... Lee N. Newcomer, M.D. $98,000 cash fees and $349,988 stock awards totaling $447,988.